Abstract
BackgroundDespite growing interest and urges by leading experts for the routine collection of patient reported outcome (PRO) measures in all general care patients, and in particular cancer patients, there has not been an updated comprehensive review of the evidence regarding the impact of adopting such a strategy on patients, service providers and organisations in an oncologic setting.MethodsBased on a critical analysis of the three most recent systematic reviews, the current systematic review developed a six-method strategy in searching and reviewing the most relevant quantitative studies between January 2000 and October 2011 using a set of pre-determined inclusion criteria and theory-based outcome indicators. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system was used to rate the quality and importance of the identified publications, and the synthesis of the evidence was conducted.ResultsThe 27 identified studies showed strong evidence that the well-implemented PROs improved patient-provider communication and patient satisfaction. There was also growing evidence that it improved the monitoring of treatment response and the detection of unrecognised problems. However, there was a weak or non-existent evidence-base regarding the impact on changes to patient management and improved health outcomes, changes to patient health behaviour, the effectiveness of quality improvement of organisations, and on transparency, accountability, public reporting activities, and performance of the health care system.ConclusionsDespite the existence of significant gaps in the evidence-base, there is growing evidence in support of routine PRO collection in enabling better and patient-centred care in cancer settings.
Highlights
Despite growing interest and urges by leading experts for the routine collection of patient reported outcome (PRO) measures in all general care patients, and in particular cancer patients, there has not been an updated comprehensive review of the evidence regarding the impact of adopting such a strategy on patients, service providers and organisations in an oncologic setting
Some rationales [25,26,27,28] put forward for measuring PROs in a cancer setting include, but not limited to: 1) better communication and shared decision making by patients and providers; 2) assessing the health status of patients entering therapy and identifying treatable problems; 3) determining the degree and sources of the patient’s decreased ability to function; 4) distinguishing between types of problems, including physical, emotional, and social; 5) detecting adverse effects of therapy; 6) monitoring the effects of disease progression and response to therapy; 7) informing decisions about changing treatment plans, and 8) predicting the course of disease and outcomes of care
Adopted the strategy used by Valderas et al [27] and Espallargues et al [29] which involved searching for the terms ‘health status’, ‘functional status’ or ‘quality of life’ and ‘clinical practice’, ‘clinical setting’, ‘practice setting’, ‘medical practice’ or ‘medical consultation’ anywhere in the title, abstract or keywords
Summary
Despite growing interest and urges by leading experts for the routine collection of patient reported outcome (PRO) measures in all general care patients, and in particular cancer patients, there has not been an updated comprehensive review of the evidence regarding the impact of adopting such a strategy on patients, service providers and organisations in an oncologic setting. Patient reported outcome (PRO) measures include health status assessments and measures for healthrelated quality-of-life (HRQOL), symptom reporting, satisfaction with care, treatment satisfaction, economic impact, and specific dimensions of patient experience such as depression and anxiety [1]. Some rationales [25,26,27,28] put forward for measuring PROs in a cancer setting include, but not limited to: 1) better communication and shared decision making by patients and providers; 2) assessing the health status of patients entering therapy and identifying treatable problems; 3) determining the degree and sources of the patient’s decreased ability to function; 4) distinguishing between types of problems, including physical, emotional, and social; 5) detecting adverse effects of therapy; 6) monitoring the effects of disease progression and response to therapy; 7) informing decisions about changing treatment plans, and 8) predicting the course of disease and outcomes of care
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
